The US Food and Drug Administration granted marketing clearances for multiple infectious disease tests and a blood culture sample preparation system, among other devices.
Kymera Therapeutics received clearance from the Food and Drug Administration for its investigational new drug application of KT-621. The clinical stage biopharmaceutical company said it expects to ...
National American University Holdings Inc (NAUH) is expected to report for 1Q. Nurix Therapeutics Inc (NRIX) is expected to report $-0.73 for 3Q. Richardson Electronics Ltd (RELL) is expected to ...